(Q44058265)

29 November 2017

title

LPA is a novel lipid regulator of mesangial cell hexokinase activity and HKII isoform expression (English)

1 reference

29 November 2017

1 reference

Platina E Coy

1

1 reference

29 November 2017

Navin Taneja

2

1 reference

29 November 2017

Iris Lee

3

1 reference

29 November 2017

Claudie Hecquet

4

1 reference

29 November 2017

Jane M Bryson

5

1 reference

29 November 2017

R Brooks Robey

6

1 reference

29 November 2017

publication date

1 August 2002

1 reference

American Journal of Physiology - Renal Physiology

29 November 2017

published in

1 reference

29 November 2017

volume

283

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

F271-9

1 reference

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Enzymatic activity of the isolated glomerulus in normal and nephrotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Lysophosphatidic acid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Lysophosphatidic acid, a multifunctional phospholipid messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Lysophosphatidic acid: G-protein signalling and cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-a

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Thrombin is a novel regulator of hexokinase activity in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

MAPK signaling and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

Malignant effusions contain lysophosphatidic acid (LPA)-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00093.2001

10.1152/AJPRENAL.00093.2001

21 January 2018

Identifiers

DOI

0 references

1 reference